QUCY NASDAQ
Mainz Biomed N.V.
1W: +693.1%
1M: +444.1%
YTD: +233.9%
$3.42
+0.90 (+35.52%)
Weekly Expected Move ±167.6%
$-8
$-2
$3
$9
$15
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$32.0M
52W Range0.3-4.8799
Volume9,649,952
Avg Volume909,820
Beta0.43
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGuido Baechler
Employees26
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2021-11-05
Websitemainzbiomed.com
Robert Koch Strasse 50
Mainz 55129
DE
Mainz 55129
DE
49 6131 554 2860
About Mainz Biomed N.V.
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Latest News
Quantum Cyber Files Provisional Patent for Quantum-Navigated Amphibious Autonomous Ground Vehicle Platform
Quantum Cyber Files Provisional Patent for Quantum-Navigated Amphibious Autonomous Ground Vehicle Platform
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tiny Defense Company Says It Has The Answer To Iran's Naval Mine Threat
Quantum Cyber Files Non-Provisional Patent Application With the USPTO for EMP-Shielding 3D-Printable Composite Filament for Drone and Defense Electronics
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Ben-Tzvi Avraham | 0 | — | 2026-04-22 | |
| NATAN DAVID | 0 | — | 2026-04-22 |